A long-running nationwide brainwashing campaign, conducted in plain sight, now comes to its deadly culmination. The predictable consequence—reviving a preventable childhood disease in the U.S.—is at hand.
More U.S. women died around the time of childbirth last year, reversing two years of decline. The CDC says 688 people died last year during pregnancy or shortly after giving birth. That’s up from 669 deaths in 2023, but down from 2022 and 2021, when it was the highest level in more than 50 years.
As artificial intelligence (AI) reshapes industries across the global economy, one of the most profound—and potentially transformative—intersections is emerging in the field of regenerative medicine. Long regarded as the frontier of biological science, regenerative therapies such as stem cell treatments, amniotic tissue applications, and advanced biologics are now experiencing a pivotal acceleration thanks to AI's analytical and educational capabilities.
The head of the FDA is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots. "We're taking a look. I can't comment on any particular application. As you know, we have a bunch of applications for those booster shots," FDA Commissioner Dr. Marty Makary says many healthcare workers did not get the last round of COVID-19 vaccine booster shots, calling it "a bit of a public trust problem."
Experts say Health and Human Services Secretary Robert F. Kennedy Jr. and other health officials’ pronouncements to lower drug costs overlooks major key issues.